Andrea Ablasser is a German immunologist who works at the École Polytechnique Fédérale de Lausanne.
Background
Ablasser was born in 1983 to a physician father and mathematician mother. She was born in Bad Friedrichshall and moved at the age of three to Buchloe, where her father was the chief physician at the Buchloer Hospital. She attended Gymnasiums in Türkheim and Hohenschwangau, and was inspired by her father to study medicine at the Ludwig Maximilian University of Munich (Ludwig Maximilian University).
Education
She completed part of her studies at the University of Massachusetts and did part of her practical training at Harvard Medical School.
Career
Her research has focused on how the innate immune system is able to recognise virus-infected cells and pathogens. When she finished her medical degree in 2008, she was ranked as one of the top ten students in Germany. Although she initially wanted to pursue oncology, she chose to write a doctoral thesis in the field of immunology, and received her doctorate from Ludwig Maximilian University in 2010.
After completing her doctorate, Ablasser followed her thesis supervisor from Ludwig Maximilian University to the University of Bonn.
She worked at the Institute of Clinical Chemistry and Clinical Pharmacology as the head of a junior research group. Her research focused on deoxyribonucleic acid sensors that allow the innate immune system to detect whether a cell is infected.
She discovered a novel second messenger molecule that is produced by a particular deoxyribonucleic acid sensor and "alerts" nearby cells when it encounters a pathogen. In 2013, she was awarded the Jürgen Wehland Prize by the Helmholtz Centre for Infection Research for her research on the mechanisms by which the innate immune system recognises pathogens, and specifically her identification of receptors and regulatory molecules that are activated in virally infected cells.
Ablasser was appointed assistant professor at the École Polytechnique Fédérale de Lausanne (École Polytechnique Fédérale de Lausanne) in the university"s Global Health Institute in 2014.